Market Closed -
Bombay S.E.
03:30:55 24/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
10.64
INR
|
-5.00%
|
|
-5.00%
|
-21.71%
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
210.8
|
909.6
|
873.2
|
853.7
|
4,005
|
226.4
|
Enterprise Value (EV)
1 |
372
|
1,116
|
1,070
|
1,051
|
4,202
|
423.5
|
P/E ratio
|
34.5
x
|
160
x
|
-3.54
x
|
-16.6
x
|
38,000
x
|
1,087
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.2
x
|
0.78
x
|
2.06
x
|
-
|
1,078
x
|
58.1
x
|
EV / Revenue
|
0.36
x
|
0.95
x
|
2.53
x
|
-
|
1,131
x
|
109
x
|
EV / EBITDA
|
13.7
x
|
32.3
x
|
-4.69
x
|
-20.4
x
|
-
|
-
|
EV / FCF
|
-3.12
x
|
-24.6
x
|
10.8
x
|
56.1
x
|
-1,67,382
x
|
-5,535
x
|
FCF Yield
|
-32.1%
|
-4.07%
|
9.24%
|
1.78%
|
-0%
|
-0.02%
|
Price to Book
|
1.41
x
|
5.85
x
|
-9.58
x
|
-5.98
x
|
-28.1
x
|
-1.59
x
|
Nbr of stocks (in thousands)
|
10,540
|
10,540
|
10,540
|
10,540
|
10,540
|
10,540
|
Reference price
2 |
20.00
|
86.30
|
82.85
|
81.00
|
380.0
|
21.48
|
Announcement Date
|
23/10/18
|
21/10/19
|
26/12/20
|
01/01/22
|
05/11/22
|
06/09/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,037
|
1,169
|
423.3
|
-
|
3.716
|
3.897
|
EBITDA
1 |
27.09
|
34.51
|
-228.3
|
-51.4
|
-
|
-
|
EBIT
1 |
27.06
|
34.44
|
-228.5
|
-51.53
|
0.2035
|
0.2082
|
Operating Margin
|
2.61%
|
2.95%
|
-53.97%
|
-
|
5.48%
|
5.34%
|
Earnings before Tax (EBT)
1 |
7.473
|
7.869
|
-246.7
|
-51.53
|
0.2035
|
0.2082
|
Net income
1 |
5.424
|
5.671
|
-246.7
|
-51.53
|
0.1523
|
0.2082
|
Net margin
|
0.52%
|
0.48%
|
-58.29%
|
-
|
4.1%
|
5.34%
|
EPS
2 |
0.5800
|
0.5381
|
-23.41
|
-4.890
|
0.0100
|
0.0198
|
Free Cash Flow
1 |
-119.3
|
-45.47
|
98.86
|
18.73
|
-0.0251
|
-0.0765
|
FCF margin
|
-11.51%
|
-3.89%
|
23.35%
|
-
|
-0.68%
|
-1.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/10/18
|
21/10/19
|
26/12/20
|
01/01/22
|
05/11/22
|
06/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
161
|
207
|
197
|
197
|
197
|
197
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.95
x
|
5.989
x
|
-0.8634
x
|
-3.835
x
|
-
|
-
|
Free Cash Flow
1 |
-119
|
-45.5
|
98.9
|
18.7
|
-0.03
|
-0.08
|
ROE (net income / shareholders' equity)
|
5.15%
|
3.71%
|
-765%
|
44.1%
|
-0.11%
|
-0.15%
|
ROA (Net income/ Total Assets)
|
5.09%
|
5.11%
|
-48.4%
|
-35.8%
|
0.21%
|
0.21%
|
Assets
1 |
106.5
|
111
|
509.5
|
144.1
|
73.77
|
98.73
|
Book Value Per Share
2 |
14.20
|
14.80
|
-8.650
|
-13.50
|
-13.50
|
-13.50
|
Cash Flow per Share
2 |
0.4200
|
0.0200
|
-
|
-
|
-
|
0
|
Capex
1 |
4.25
|
0.3
|
0.43
|
-
|
-
|
-
|
Capex / Sales
|
0.41%
|
0.03%
|
0.1%
|
-
|
-
|
-
|
Announcement Date
|
23/10/18
|
21/10/19
|
26/12/20
|
01/01/22
|
05/11/22
|
06/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -21.71% | 13.45L | | -53.68% | 1.04TCr | | -45.65% | 868.01Cr | | -26.18% | 644.64Cr | | -7.49% | 598.41Cr | | +85.61% | 490.9Cr | | -3.80% | 456.7Cr | | +5.73% | 449.08Cr | | -26.42% | 409.61Cr | | -18.65% | 257.65Cr |
Other Drug Retailers
|